MEHLMAN CONSULTING, INC.

Lobbying for ULTRAGENYX PHARMACEUTICAL, INC. · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Bills named in this filing 1

HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027

Lobbying activity 2

Health Issues

Issues relating to rare disease and patient access.

Budget/Appropriations

FY27 Appropriations (H.R.8646, Agriculture, Rural Development, Food and Drug Administration)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.